Intra-antral application of an anti-fungal agent for recurrent maxillary fungal rhinosinusitis: a case report.

Abstract

INTRODUCTION:

Fungal infection of the paranasal sinuses is an increasingly recognized entity both in immunocompetent and immunocompromised individuals. Treatment has been via use of either surgical or medical modalities, or a combination of the two. Here, we present a case of utilization of intra-antral application of an anti-fungal agent in the management of recurrent fungal sinusitis in an indigent Nigerian patient.

CASE PRESENTATION:

We present the case of a 30-year-old West African Yoruba man, an indigent Nigerian clergyman, who presented to our facility with a history of recurrent nasal discharge (about one year), recurrent nasal blockage (about five months), and right facial swelling (about one week). After intra-nasal antrostomy for debulking with a systemic anti-fungal agent, our patient had a recurrence after four months. Our patient subsequently had an intra-antral application of flumetasone and clioquinol (Locacorten®-Vioform®) weekly for six weeks with improvement of symptoms and no recurrence after six months of follow-up.

CONCLUSIONS:

We conclude that topical intra-antral application of anti-fungal agents is effective in patients with recurrent fungal maxillary sinusitis after surgical debulking.

• Authors: Adekunle D Dunmade, Olushola A Afolabi, Biodun S Alabi, Segun Segun-Busari, Olubisi A Koledoye
• Journal: Journal of medical case reports (J Med Case Rep) Vol. 6 Pg. 245 (Aug 20 2012) ISSN: 1752-1947 [Electronic] England
• PMID: 22905703 (Publication Type: Journal Article)